Modeling Bronchial Epithelium Modifications Associated With COPD Using iPS

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

August 7, 2017

Primary Completion Date

March 9, 2022

Study Completion Date

March 9, 2022

Conditions
Pulmonary Disease, Chronic ObstructiveSmoking
Interventions
PROCEDURE

Bronchial biopsy

The bronchial biopsy is part of this study's inclusion criteria and is required during routine care for the patient. Bronchial fibroscopy is performed under general or local anesthesia. Biopsies are performed using forceps and according to current recommendations. One biopsy will be fixed immediately in RCL2 medium while the others (between 3 and 6) will be kept in isotonic saline and rapidly prepared for air-liquid-interface (ALI) cell culture.

PROCEDURE

Skin biopsy

The skin biopsy will be performed after local anesthesia by hypodermic injection of a 1% Xylocaine solution. A single sample of a skin fragment about 3 mm in diameter will be necessary.

PROCEDURE

Blood sample

The blood sample will be taken at the end of the cutaneous biospy, approximately 20 ml of blood will be collected.

Trial Locations (1)

34295

Centre Hospitalier Universitaire de Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT03181204 - Modeling Bronchial Epithelium Modifications Associated With COPD Using iPS | Biotech Hunter | Biotech Hunter